Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Guggenheim Initiates Coverage On IDEAYA Biosciences with Buy Rating, Announces Price Target of $50

Author: Benzinga Newsdesk | September 18, 2025 08:00am

Guggenheim analyst Paul Jeng initiates coverage on IDEAYA Biosciences (NASDAQ:IDYA) with a Buy rating and announces Price Target of $50.

Posted In: IDYA